Aussie
Why wait till the end of July when they haven't lodged the March quarterly let alone the half yearly?
The ASIC probably not interested in half yearly reports and I don't think the ASX worries while a company is in suspension.
Anyway, IMO full year receipts will be around $200K and cash will be down to about $5M or less given the legal fees and the number of consultants being used on the various investment options (all which will probably amount to zero).
- Forums
- ASX - By Stock
- CGB
- Ann: WESTERN SYDNEY UNIVERSITY TO UNDERTAKE CLINICAL TRIALS
Ann: WESTERN SYDNEY UNIVERSITY TO UNDERTAKE CLINICAL TRIALS, page-38
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online